Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 20

1.

Long-term incobotulinumtoxinA treatment for chronic sialorrhea: Efficacy and safety over 64 weeks.

Jost WH, Friedman A, Michel O, Oehlwein C, Slawek J, Bogucki A, Ochudlo S, Banach M, Pagan F, Flatau-Baqué B, Dorsch U, Csikós J, Blitzer A.

Parkinsonism Relat Disord. 2019 Nov 26;70:23-30. doi: 10.1016/j.parkreldis.2019.11.024. [Epub ahead of print]

PMID:
31794936
2.

SIAXI: Placebo-controlled, randomized, double-blind study of incobotulinumtoxinA for sialorrhea.

Jost WH, Friedman A, Michel O, Oehlwein C, Slawek J, Bogucki A, Ochudlo S, Banach M, Pagan F, Flatau-Baqué B, Csikós J, Cairney CJ, Blitzer A.

Neurology. 2019 Apr 23;92(17):e1982-e1991. doi: 10.1212/WNL.0000000000007368. Epub 2019 Mar 27.

3.

Towards unambiguous reporting of complications related to deep brain stimulation surgery: A retrospective single-center analysis and systematic review of the literature.

Engel K, Huckhagel T, Gulberti A, Pötter-Nerger M, Vettorazzi E, Hidding U, Choe CU, Zittel S, Braaß H, Ludewig P, Schaper M, Krajewski K, Oehlwein C, Mittmann K, Engel AK, Gerloff C, Westphal M, Moll CKE, Buhmann C, Köppen JA, Hamel W.

PLoS One. 2018 Aug 2;13(8):e0198529. doi: 10.1371/journal.pone.0198529. eCollection 2018.

4.

[Parkinson Disease and Pain - diagnostic and therapeutic approaches to a challenging non-motor symptom].

Buhmann C, Ip CW, Oehlwein C, Tönges L, Wolz M, Reichmann H, Kassubek J.

Fortschr Neurol Psychiatr. 2018 Sep;86(S 01):S48-S58. doi: 10.1055/a-0590-4464. Epub 2018 Jul 17. Review. German.

PMID:
30016807
5.

Nonmotor fluctuations: phenotypes, pathophysiology, management, and open issues.

Classen J, Koschel J, Oehlwein C, Seppi K, Urban P, Winkler C, Wüllner U, Storch A.

J Neural Transm (Vienna). 2017 Aug;124(8):1029-1036. doi: 10.1007/s00702-017-1757-0. Epub 2017 Jul 12. Review.

PMID:
28702850
6.

Adverse events in deep brain stimulation: A retrospective long-term analysis of neurological, psychiatric and other occurrences.

Buhmann C, Huckhagel T, Engel K, Gulberti A, Hidding U, Poetter-Nerger M, Goerendt I, Ludewig P, Braass H, Choe CU, Krajewski K, Oehlwein C, Mittmann K, Engel AK, Gerloff C, Westphal M, Köppen JA, Moll CKE, Hamel W.

PLoS One. 2017 Jul 5;12(7):e0178984. doi: 10.1371/journal.pone.0178984. eCollection 2017.

7.

Patients' perception of Parkinson's disease-associated pain following initiation of rotigotine: a multicenter non-interventional study.

Timmermann L, Oehlwein C, Ransmayr G, Fröhlich H, Will E, Schroeder H, Lauterbach T, Bauer L, Kassubek J.

Postgrad Med. 2017 Jan;129(1):46-54. doi: 10.1080/00325481.2017.1258953. Epub 2016 Nov 24.

PMID:
27883297
8.

Impact of Deep Brain Stimulation on Daily Routine Driving Practice in Patients with Parkinson's Disease.

Buhmann C, Vettorazzi E, Oehlwein C, Rikkers F, Poetter-Nerger M, Gulberti A, Gerloff C, Moll CK, Hamel W.

Parkinsons Dis. 2015;2015:608961. doi: 10.1155/2015/608961. Epub 2015 Nov 10.

9.

Effect of neurostimulation on camptocormia in Parkinson's disease depends on symptom duration.

Schulz-Schaeffer WJ, Margraf NG, Munser S, Wrede A, Buhmann C, Deuschl G, Oehlwein C.

Mov Disord. 2015 Mar;30(3):368-72. doi: 10.1002/mds.26081. Epub 2015 Feb 12.

10.

Implementing conventional Zamorano Dujovny frames versus individually manufactured microTargeting platforms--a comparative study on deep brain stimulation in Parkinson patients.

Winkler D, Hammer N, Oehlwein C, Schwarz J, Strecker K, Fritzsch D, Meixensberger J.

Stereotact Funct Neurosurg. 2013;91(6):392-8. doi: 10.1159/000351522. Epub 2013 Oct 9.

PMID:
24108216
11.

STN stimulation in general anaesthesia: evidence beyond 'evidence-based medicine'.

Moll CK, Payer S, Gulberti A, Sharrott A, Zittel S, Boelmans K, Köppen J, Gerloff C, Westphal M, Engel AK, Oehlwein C, Buhmann C, Hamel W.

Acta Neurochir Suppl. 2013;117:19-25. doi: 10.1007/978-3-7091-1482-7_4.

PMID:
23652652
12.

Switch from selegiline to rasagiline is beneficial in patients with Parkinson's disease.

Müller T, Hoffmann JA, Dimpfel W, Oehlwein C.

J Neural Transm (Vienna). 2013 May;120(5):761-5. doi: 10.1007/s00702-012-0927-3. Epub 2012 Nov 30.

PMID:
23196982
13.

Monoamine transporter availability in Parkinson's disease patients with or without depression.

Hesse S, Meyer PM, Strecker K, Barthel H, Wegner F, Oehlwein C, Isaias IU, Schwarz J, Sabri O.

Eur J Nucl Med Mol Imaging. 2009 Mar;36(3):428-35. doi: 10.1007/s00259-008-0979-7. Epub 2008 Nov 27.

PMID:
19037640
14.

Kinetic analyses of [123I]IBZM SPECT for quantification of striatal dopamine D2 receptor binding: a critical evaluation of the single-scan approach.

Meyer PT, Sattler B, Winz OH, Fundke R, Oehlwein C, Kendziorra K, Hesse S, Schaefer WM, Sabri O.

Neuroimage. 2008 Aug 15;42(2):548-58. doi: 10.1016/j.neuroimage.2008.05.023. Epub 2008 May 23.

PMID:
18595739
15.

Effects of subthalamic nucleus stimulation on striatal dopaminergic transmission in patients with Parkinson's disease within one-year follow-up.

Hesse S, Strecker K, Winkler D, Luthardt J, Scherfler C, Reupert A, Oehlwein C, Barthel H, Schneider JP, Wegner F, Meyer P, Meixensberger J, Sabri O, Schwarz J.

J Neurol. 2008 Jul;255(7):1059-66. doi: 10.1007/s00415-008-0849-z. Epub 2008 May 2.

PMID:
18446306
16.

Possible impact of dopamine SPECT on decision-making for drug treatment in Parkinsonian syndrome.

Hesse S, Oehlwein C, Barthel H, Schwarz J, Polster D, Wagner A, Sabri O.

J Neural Transm (Vienna). 2006 Sep;113(9):1177-90. Epub 2006 Feb 6.

PMID:
16463120
17.

Efficacy and safety of high-dose cabergoline in Parkinson's disease.

Odin P, Oehlwein C, Storch A, Polzer U, Werner G, Renner R, Shing M, Ludolph A, Schüler P.

Acta Neurol Scand. 2006 Jan;113(1):18-24.

PMID:
16367894
18.

High-dose treatment with pergolide in Parkinson's disease patients with motor fluctuations and dyskinesias.

Storch A, Trenkwalder C, Oehlwein C, Winkelmann J, Polzer U, Hundemer HP, Schwarz J.

Parkinsonism Relat Disord. 2005 Sep;11(6):393-8.

PMID:
15993640
19.

Dementia in idiopathic Parkinson's syndrome.

Fuchs GA, Gemende I, Herting B, Lemke MR, Oehlwein C, Reichmann H, Rieke J, Emmans D, Volkmann J.

J Neurol. 2004 Sep;251 Suppl 6:VI/28-32. Review.

PMID:
15675722
20.

Depression and Parkinson's disease.

Lemke MR, Fuchs G, Gemende I, Herting B, Oehlwein C, Reichmann H, Rieke J, Volkmann J.

J Neurol. 2004 Sep;251 Suppl 6:VI/24-7. Review.

PMID:
15675721

Supplemental Content

Loading ...
Support Center